Nalinikrishna Kumar Doniparthi MD CEO
Addiction Medicine, Complementary and Integrative Medicine, Obesity Medicine & Nutrition
Physician
Join to View Full Profile
401 S Main StSte C1Alpharetta, GA 30009
Phone+1 678-242-0204
Fax+1 678-242-0406
Dr. Doniparthi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Chief Medical Officer and Clinical Medical Director for NeuroLipid Research Foundation. Working in private practice for cellular regeneration in chronic medical conditions but especially neurological conditions such as autism, ALS, seizure NOS, TBI, Parkinson's, post-stroke, dementia, toxic mold, Lyme, etc. Also perform intravenous infusions for addiction using NAD+.
Education & Training
University of Alabama Medical CenterResidency, Family Medicine, 2002 - 2005
Hope Univ Sch Med- BelmopanClass of 2000- Grace University School of MedicineClass of 2000
Certifications & Licensure
GA State Medical License 2005 - 2025
WI State Medical License 2019 - 2021
AL State Medical License 2002 - 2019
American Board of Obesity Medicine Obesity Medicine
Publications & Presentations
PubMed
- 49 citationsVascular endothelial growth factor monoclonal antibody inhibits growth of anaplastic thyroid cancer xenografts in nude mice.Andrew J. Bauer, Richard Terrell, Nalinikrishna K. Doniparthi, Aneeta Patel, R. Michael Tuttle
Thyroid. 2002-11-01
Professional Memberships
- Member
- Member
- Member
Other Languages
- Telugu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
